U.S. Home Infusion Therapy Market Size Is Estimated To Reach $17.8 Billion By 2026

According to a report, “U.S. Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-Infective, Endocrinology), And Segment Forecasts, 2019 - 2026” published by Grand View Research, Inc., The U.S. home infusion therapy market size is expected to reach USD 17.8 billion by 2026, registering a CAGR of 4.9% during the forecast period. The rising geriatric population and prevalence of health conditions such as cancer, immune deficiencies, Crohn's disease, infections, dehydration, nutritional deficiencies, multiple sclerosis, and gastrointestinal diseases are driving the demand for home infusion therapy in the country.

Growing cases of Hospital Acquired Infections (HAI) is another major driver for the U.S. market for home infusion therapy. According to the US Center for Disease Control and Prevention (CDC), annually, approximately 1.7 million admitted patients are affected by Health Care-associated infections (HCAI), and around 98,000 patients-one in every 17 patients- die due to HCAIs. This factor is anticipated to substantially drive the demand for home infusion therapy.

Increasing innovations in home infusion therapy such as the incorporation of Electronic Healthcare Records (EHR) along with medical devices and infusion pumps are expected to further fuel the market in the forthcoming years. The EHRs allow storage, retrieval, and alteration of medical records, making it easier for healthcare professionals and patients to track improvements in the particular health condition.

Full Research Report On U.S. Home Infusion Therapy Market Visit Here: https://www.grandviewresearch.com/industry-analysis/us-home-infusion-therapy-market

U.S. Home Infusion Therapy Market Report Highlights

1. On the basis of product, Infusion pumps segment held the largest market share in 2018, due to increasing use and efficiency in delivering required quantities of nutrition, medications, and other essential fluids.
2. The needleless connectors segment is anticipated to lead the product segment with the fastest CAGR over the forecast period.
3. On the basis of application, the anti-infective application segment held the maximum share of the U.S. home infusion therapy market in 2018 owing to extensive use as antifungal, antibiotics, and antiviral agents at-home care.
4. The endocrinology application segment is projected to register the fastest CAGR over the forecast period, owing to a growing number of conditions associated with the endocrine system, such as thyroid and diabetes.
5. In April 2020, B. Braun Medical Inc. announced that it has received emergency use authorization from the US Food and Drug Administration (FDA) for the use of infusion pumps with nebulizers to treat COVID-19 patients.

Request a Sample Copy of the Report @ https://www.grandviewresearch.com/industry-analysis/us-home-infusion-therapy-market/request/rs1

U.S. Home Infusion Therapy Market Segmentation

Grand View Research has segmented the U.S. home infusion therapy market based on product and application:

U.S. Home Infusion Therapy Product Outlook (Revenue, USD Million, 2014 - 2026)

1. Infusion Pumps
1. Ambulatory Infusion Pumps
2. Insulin Pumps
3. Syringe Pumps
4. Elastomeric Pumps
5. Patient Controlled Analgesics (PCA)
6. Volumetric Pumps
2. Intravenous Sets
3. IV Cannulas
4. Needleless Connectors

U.S. Home Infusion Therapy Application Outlook (Revenue, USD Million, 2014 - 2026)

1. Anti-Infective
1. Diabetes
2. Others
2. Endocrinology
3. Hydration Therapy
1. Athletes
2. Others
4. Chemotherapy
5. Enteral Nutrition
6. Parenteral Nutrition
7. Specialty Pharmaceuticals
8. Others

Key Players in the U.S. Home Infusion Therapy Market

1. B. Braun Melsungen
2. Baxter International
3. Caesarea Medical Electronics Ltd.
4. CareFusion
5. Fresenius Kabi
6. ICU Medical
7. JMS CO., LTD.
8. Smiths Medical, Inc.
9. Terumo Corporation
10. Coram LLC
11. Option Care Enterprises, Inc.
12. BioScrip, Inc.
13. BriovaRx Infusion Services
14. Paragon Healthcare.

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com